Jefferies lifts Pro Medicus PT after Virtua Health contract win

By Reuters News

** Jefferies raises its price target on Pro Medicus PME.AX to A$199 from A$198.30 and maintains a "hold" rating

** Healthtech software maker signs a seven-year A$43 million ($30.23 million) contract with Virtua Health covering Visage 7 Viewer, Workflow, Cardiology and Open Archive

** Brokerage expects revenue from the contract to begin at the start of FY28

** Adds its forecasts already assume future contract wins, so the deal does not materially change near to medium-term estimates

** Jefferies expects company to have further contract wins in FY27 and beyond

** YTD, stock down 16.3%, as of last close


($1 = 1.4223 Australian dollars)

Capital.com is an execution-only brokerage platform and the content provided on the Capital.com website is intended for informational purposes only and should not be regarded as an offer to sell or a solicitation of an offer to buy the products or securities to which it applies. No representation or warranty is given as to the accuracy or completeness of the information provided.

The information provided does not constitute investment advice nor take into account the individual financial circumstances or objectives of any investor. Any information that may be provided relating to past performance is not a reliable indicator of future results or performance.

To the extent permitted by law, in no event shall Capital.com (or any affiliate or employee) have any liability for any loss arising from the use of the information provided. Any person acting on the information does so entirely at their own risk.

Any information which could be construed as “investment research” has not been prepared in accordance with legal requirements designed to promote the independence of investment research and as such is considered to be a marketing communication.